Down in the Weeds: Automated Fast Screening Workflow for Cannabinoids in Whole Blood Using High Resolution Mass Spectrometry

Significance of the topic

Rapid and reliable differentiation of psychoactive THC isomers, their metabolites, non‑psychoactive isobars and emergent semi‑synthetic cannabinoids (e.g., HHC) in whole blood is a growing requirement in forensic and clinical toxicology. High‑resolution mass spectrometry (HRMS) combined with automated chromatographic workflows enables high throughput screening while maintaining the chromatographic and spectral specificity needed to confidently identify isomeric and isobaric compounds. The workflow described offers a pragmatic balance between laboratory throughput and analytical certainty, with the additional advantage of retrospective data interrogation to detect novel analytes.

Objectives and overview of the study

Summarize and evaluate an automated two‑stage LC/HRMS workflow for cannabinoids in whole blood that:

• Implements a fast MS‑only screening method to maximize sample throughput (4 min run time).
• Automatically reflexes putative positives above a defined cutoff to a longer, isomer‑resolving All Ions chromatographic method (15 min) for confirmation.
• Demonstrates extraction, sensitivity, linearity and robustness for a panel of THC isomers, metabolites and related cannabinoids including HHC.
• Enables retrospective library and fragment interrogation using All Ions acquisition.

Methodology

Sample preparation and extraction:

• Starting matrix: 500 µL whole blood.
• Protein precipitation by addition of 1.2 mL cold acetonitrile:methanol (85:15, v/v), vortex and centrifugation to pellet proteins.
• Supernatant passed through Captiva EMR‑Lipid filtration cartridges under positive pressure to reduce lipid interferences and clean extract.
• Rinse step with ACN:H2O to improve analyte recovery.
• Evaporation to dryness under nitrogen at 45 °C and reconstitution in 100 µL MeOH:H2O (50:50, v/v) prior to LC injection.

Chromatography and acquisition:

• First‑pass fast screen: C18 column, MS‑only acquisition, 4‑minute runtime—optimized to separate target peaks from major matrix interferences while minimizing false positives.
• Reflex second‑pass: Poroshell 120 PFP column with an established longer chromatographic method (15 min) using All Ions acquisition to obtain fragment information and baseline separation of THC isomers and metabolites.
• Automatic reflex logic in the Revident LC/Q‑TOF system: putative positives above a user‑defined cutoff are reinjected either immediately (with blank injection to equilibrate) or appended to the end of the batch for secondary analysis.

Used instrumentation

• Revident LC/Q‑TOF system coupled with Agilent 1290 Infinity II LC.
• Columns: C18 for the fast screen; Poroshell 120 PFP for the isomer‑resolving confirmation method.
• Sample cleanup: Captiva EMR‑Lipid filtration cartridges.
• Acquisition modes: MS‑only for screening; All Ions HRMS for confirmation and retrospective fragment analysis.

Results and discussion

• Sensitivity and linearity: Calibration ranges tested between ~1–500 ng/mL (representative calibration shown 5–500 ng/mL); most analytes showed LOQs ≈ 5 ng/mL, with HHC LOQ ≈ 10 ng/mL.
• Reproducibility: Good precision and linear response were reported across the tested range for all analytes on both chromatographic methods.
• Chromatographic performance: The short 4‑min method was tuned to keep matrix interferences separated from analyte windows, thereby minimizing unnecessary reflexes. The 15‑min PFP method achieved baseline separation of THC isomers and their hydroxy/carboxy metabolites, enabling confident identification.
• Automated reflex logic: Using a 10 ng/mL cutoff (aligned with SWGTOX recommendations and experimental validation), putative positives were automatically flagged and reinjected for confirmatory analysis. The system supports an append workflow to prioritize throughput and schedule reflexed injections after the initial batch is screened, with built‑in blank injections for column equilibration before the secondary method runs.
• All Ions capability: The long method’s All Ions acquisition permits retrospective interrogation of MS/MS fragments, supporting identification of known and emerging cannabinoid analogs without reanalysis of the original extracts.

Benefits and practical applications

• Throughput: The fast‑screen/reflex approach increases sample throughput by avoiding full confirmatory runs for negative samples while retaining confirmatory power for positives.
• Analytical certainty: Baseline chromatographic separation on the second method plus high‑resolution mass spectral data reduce false positives due to isobars and isomers.
• Operational efficiency: Automated decision logic and flexible worklist handling (immediate vs appended reflex injections) streamline laboratory workflows and reduce manual interventions.
• Forensic relevance: The workflow supports up‑to‑date interrogation for novel synthetic cannabinoids, critical in toxicology casework where new analogs continually appear.

Future trends and potential uses

• Expansion of HRMS spectral libraries and data‑mining tools to improve detection and retrospective identification of novel cannabinoid analogs and metabolites.
• Greater integration with laboratory information management systems (LIMS) and automated reporting to accelerate case turnaround and QC tracking.
• Further automation of sample preparation (e.g., online SPE or robotic liquid handling) to raise throughput and reproducibility in high‑volume forensic labs.
• Application of machine learning and advanced spectral deconvolution to distinguish coeluting isomers and improve low‑level detections in complex matrices.
• Extension of the reflex approach to quantitative confirmation workflows and full validation across broader panels including other drug classes and metabolites.

Conclusion

The described two‑step automated LC/HRMS workflow provides an effective compromise between speed and definitive identification for cannabinoids in whole blood. A rapid MS‑only screen minimizes instrument time for negative samples, while automated reflex to a longer All Ions chromatographic method ensures baseline separation of THC isomers and supports fragment‑based confirmation. The approach improves laboratory throughput, preserves forensic confidence, and leverages HRMS retrospective capabilities to address the evolving landscape of novel cannabinoids.

References

1. Stevens J, Zhao L. Efficient Quantitative Analysis of THC and its Metabolites in Whole Blood Using Agilent Captiva EMR‑Lipid and LC‑MS/MS. Agilent Application Note 5991‑8635EN, 2020.
2. Stone PJW, et al. Quantitative Separation of THC Isomers and Metabolites from Whole Blood. Agilent Application Note 5994‑8664EN, 2025.